Latest Conference Articles

September 11th 2025

Susan J. Schniepp, Distinguished Fellow, Regulatory Compliance Associates, joins PDA CEO Glenn Wright and Melissa Seymour, Executive Vice President, Global Quality, Eli Lilly and Company, to talk about the regulatory and quality topics discussed at the 2025 PDA Regulatory Conference.

September 10th 2025

AI can offer a strategic blueprint for GxP compliance, risk mitigation, and human-led operational excellence.

September 10th 2025

FDA experts at PDA 2025 urges pharma to adopt holistic quality systems, strengthening 483 responses & post-warning letter remediation for compliance excellence.

September 9th 2025

PDA Regulatory Conference

Charles Gibbons of Lachman Consultants and Michael Grischeau of AbbVie stressed AI governance, data integrity, and human oversight as essential to applying digital tools across labs and supply chains.

September 9th 2025

September 9th 2025

Bothe data integrity and quality of data are critical for drug discovery, manufacturing efficiency, regulatory compliance, and patient safety.

September 8th 2025

Glenn Wright previews the 34th PDA Regulatory Conference, spotlighting AI, quality culture, FDA trends, and collaboration shaping industry progress.

July 22nd 2025

The trade show is expected to draw 35,000 attendees to a show floor netting more than 1 million square feet.

July 1st 2025

BIO International Convention

In contrast to earlier conferences in 2025, experts interviewed as part of the BIO conference in Boston did not come to a consensus about lasting impacts of recent changes in US government policy.

June 20th 2025

BIO International Convention

The department’s newly announced partnerships were part of a weeklong visit that included discussions held at BIO 2025.